I undersøgelsesr af botulinum type A- neurotoksinkompleks hos patienterforekom synkebesvær mindre hyppigt med lave doser.
In clinical trials with Botulinum toxin type A complex, it was reported that swallowing difficulties occur less frequently with low doses.